Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

Abstract Objective To report initial results of a planned multicenter year‐long prospective study examining the risk and impact of COVID‐19 among persons with neuroinflammatory disorders (NID), particularly multiple sclerosis (MS). Methods In April 2020, we deployed online questionnaires to individu...

Full description

Bibliographic Details
Main Authors: Seth N. Levin, Shruthi Venkatesh, Katie E. Nelson, Yi Li, Ines Aguerre, Wen Zhu, Karman Masown, Kathryn T. Rimmer, Claudiu I. Diaconu, Kaho B. Onomichi, Victoria M. Leavitt, Libby L. Levine, Rebecca Strauss‐Farber, Wendy S. Vargas, Brenda Banwell, Amit Bar‐Or, Joseph R. Berger, Andrew D. Goodman, Erin E. Longbrake, Jiwon Oh, Bianca Weinstock‐Guttman, Kiran T. Thakur, Keith R. Edwards, Claire S. Riley, Zongqi Xia, Philip L. De Jager, Multiple Sclerosis Resilience to COVID‐19 (MSReCOV) Collaborative
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51314

Similar Items

Similar Items